Clinical Trial Update: Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years

View source ↗

Summary

Post-marketing safety monitoring study of fluticasone propionate in Chinese children aged 1 to under 4 with asthma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Status: COMPLETED | Results posted: 2019-10-02